Novavax (NVAX) Could Catch Bid as World Catches the Flu - FBR Capital
Tweet Send to a Friend
FBR Capital analyst William Tanner, Ph.D reiterated an Outperform rating and $11 price target on Novavax (NASDAQ: NVAX) saying pandemic ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
